Invention Grant
- Patent Title: Engineered nucleic-acid targeting nucleic acids
-
Application No.: US16907115Application Date: 2020-06-19
-
Publication No.: US11225649B2Publication Date: 2022-01-18
- Inventor: Paul Daniel Donohoue , Andrew Paul May
- Applicant: Caribou Biosciences, Inc.
- Applicant Address: US CA Berkeley
- Assignee: Caribou Biosciences, Inc.
- Current Assignee: Caribou Biosciences, Inc.
- Current Assignee Address: US CA Berkeley
- Agent Olga Kay
- Main IPC: C12N9/22
- IPC: C12N9/22 ; C12N9/96 ; C12N15/113 ; C12N15/90 ; C12N15/10

Abstract:
The present disclosure provides engineered cross-type-nucleic-acid targeting nucleic acids and compositions thereof. Nucleic acid sequences encoding the engineered cross-type-nucleic-acid targeting nucleic acids, as well as expression cassettes, vectors and cells comprising such nucleic acid sequences, are described. Also, methods are disclosed for making and using the engineered cross-type-nucleic-acid targeting nucleic acids and compositions thereof.
Public/Granted literature
- US20200318088A1 Engineered Nucleic-Acid Targeting Nucleic Acids Public/Granted day:2020-10-08
Information query